A detailed history of Ardsley Advisory Partners LP transactions in Profound Medical Corp. stock. As of the latest transaction made, Ardsley Advisory Partners LP holds 275,000 shares of PROF stock, worth $1.93 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
275,000
Previous 215,000 27.91%
Holding current value
$1.93 Million
Previous $1.8 Million 21.41%
% of portfolio
0.39%
Previous 0.29%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.47 - $11.18 $448,200 - $670,800
60,000 Added 27.91%
275,000 $2.19 Million
Q2 2024

Aug 14, 2024

BUY
$7.25 - $9.07 $507,500 - $634,900
70,000 Added 48.28%
215,000 $1.8 Million
Q1 2024

May 15, 2024

BUY
$7.3 - $9.46 $1.06 Million - $1.37 Million
145,000 New
145,000 $1.24 Million
Q1 2020

May 15, 2020

SELL
$6.88 - $19.7 $68,800 - $197,000
-10,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$6.4 - $11.95 $64,000 - $119,500
10,000 New
10,000 $114,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $146M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.